There is a growing consensus to include preschool-aged children in preventive 27 chemotherapy programs with praziquantel, aiming to control schistosomiasis. 28
respectively). Children's demographics and parasitological characteristics are 125 summarised in more details in Table 1 . 126
Non-compartmental analysis 127
PK parameters are summarised in Table 2 for S. mansoni and in Table 3 for S. 128 haematobium, presented as medians with interquartile range (IQR). Concentration-129 over-time profiles of R-and SPZQ and the metabolite for S. mansoni and S. 130 haematobium SAC and PSAC are presented in Figures 1 and 2 , respectively. 131
Overall, a great inter-patient variability was observed. T 1/2 could be estimated in 75 132 (70-81)% of subjects and was similar for all analytes across different dosages and the 133 two age groups and parasite species, at approximately 3-8 h for R-and SPZQ and 2-5 134 h for the metabolite. T max was 1.5 to 6 h for the metabolite, while the enantiomers 135 attained their highest concentration in blood at 0.5-3.0 h in the four populations of 136 children studied. 137
In S. mansoni-infected SAC, the highest C max values were observed at 60 mg/kg for 138 R-trans-4-OH-PZQ (13.57; 9.81-16.43 μg/ml), followed by SPZQ (1.00; 0.62-1.37 139 μg/ml) and RPZQ (0.29; 0.22-0.53 μg/ml). PSACs revealed considerably higher C max 140 compared to SAC for all three analytes as summarised in Tables 2 and 3 . In the S. 141 haematobium study, in SAC, the highest values for C max at 60 mg/kg PZQ were 142 observed for R-trans-4-OH-PZQ (11.49; 9.05-13.78 μg/ml), followed by SPZQ 143 (1.25; 0.78-1.86 μg/ml) and RPZQ (0.44; 0.25-0.81 μg/ml). PSAC revealed similar 144 C max and no differences were observed compared to PSAC for any dose or analyte. analytes, at any dose, was observed. Logistic regression confirmed this finding-a 150 significant effect of dose on AUC was found for children, infected with S. mansoni, 151
but not for children infected with S. haematobium. 152
When comparing the AUC of cured and uncured PSAC using Mann-Whitney 153 analysis, no differences were observed for any of the analytes and both species of the 154 parasite, while cured SAC infected with S. mansoni were reaching significantly higher 155
AUCs compared to uncured. S. haematobium infected SAC revealed significantly 156
higher AUC values of RPZQ and SPZQ between cured and uncured children, while 157 there was no significant difference in metabolite exposure (data not shown). Logistic 158 regression indicated a positive relationship between RPZQ exposure (for both AUC 159
and Cmax) and probability of cure, in which higher exposure led to higher probability 160 of cure, for all children analysed together, as shown in Figures 3 and 4 . 161
Discussion 162
Schistosomiasis remains a considerable public health problem, despite the years of 163 efforts to control it (2, 3). PZQ is the treatment of choice and has been successfully 164 used for decades (7, 8) . While SAC are treated regularly, PSAC have been up to this 165 day either excluded from preventive chemotherapy programs or treated off-label with 166 the WHO recommended dose of 40 mg/kg PZQ, used for adults and SAC (11, 12, 25) . 167
To date, several studies have been conducted describing efficacy and safety of PZQ in 168 young children (13, 26, 27) . PK of PZQ has been studied mostly in healthy adults 169 (28-31), while ADME processes of PZQ in children, except for the recent study by 170 explore the PK of a large cohort of children treated with 3 different dosages of PZQ in 175 both age groups of children, PSAC and SAC, infected with either S. mansoni or S. 176 haematobium. The sampling technique used was novel DBS technology, which 177 proved to be an excellent tool. It does not require medical staff or a hospital 178 environment, which is crucial for rural settings. Furthermore, collection of blood is 179 comparably less invasive than venepuncture, which is a benefit for sensitive 180 populations, such as children. Adding up to these advantages are also the transport 181 conditions-DBS do not require a cold chain and can be easily transported from the 182 field to the laboratory (32, 33) . 183
We did not observe pronounced differences in PK parameters between SAC and 184 PSAC and between species-specific infections (Tables 2 and 3 ). While we observed 185 significantly higher exposure for the enantiomers (R-and SPZQ) in PSAC compared 186 to SAC, infected with S. mansoni, the metabolite was present in significantly lower 187 quantities. This finding could indicate slower metabolism and lower clearance in 188 young children compared to their older peers. Interestingly, these differences were not 189 significant in children harbouring urinary schistosomiasis. 190
The debate about which analyte is driving the antischistosomal activity of PZQ is still 191 ongoing. In a recent PK study in S. mansoni-infected children, Bustinduy et al 192 proposed SPZQ to be the eutomer, since it exhibited a higher and longer exposure 193 (AUC and half-life) compared to RPZQ (16). They also suggested a correlation 194 between AUC of PZQ, in particular of SPZQ, and CR. In our study, we observed 195 The observed interspecies differences in susceptibility to PZQ enantiomers and their 203 impact on efficacy of the drug in human, is an important issue. We recently showed 204 that SPZQ had a higher and significant efficacy against S. haematobium compared to 205 S. mansoni both in vitro and in vivo. It might therefore contribute to the overall 206 activity of PZQ on S. haematobium. R-trans-4-OH-PZQ also showed signs of 207 antischistosomal activity in vitro towards both species of the parasite, more 208 pronounced in case of S. haematobium (21) . Its contribution to the activity of RPZQ 209 could explain a higher sensitivity of S. haematobium to PZQ within in vitro/in vivo 210 frame, however in our studies we did not observe any correlation between exposure of 211 the metabolite and probability of cure. 212
In conclusion, we have described PK processes of PZQ in a pediatric population using 213 three different dosages and comparing the two most prevalent species of Schistosoma 214 spp. Based on our findings, the species of schistosome infection (S. mansoni versus S. 215 haematobium) does not play a role in influencing PK parameters of PZQ. Age seems 216 to have an effect however no clear pattern has been observed. While SPZQ is present 217 in higher quantities than RPZQ, it did not show a relationship with CRs, while logistic 218 regression indicated a positive relationship between RPZQ exposure and cure. 219
Population pharmacokinetics studies with RPZQ are currently on going to study the 220 patterns and eventual relationships of patients' characteristics (e.g. weight, co-221 infections) with PK parameters in more detail. 222 
Methods and materials 223

Chemicals and reagents
LC-MS/MS method and partial validation 244
The LC-MS/MS method was adapted from a recently validated method by Meister et 245 al (34). Briefly, the compounds of interest were primarily separated from remaining 246 matrix by a column trapping system (HALO C-18, 4.6 x 5 mm, Optimize 247
Technologies, OR, USA), to minimize instrument contamination. 10 mM ammonium 248 acetate with 0.015% formic acid in water (mobile phase A) at a flow rate of 0.3 249 on June 8, 2018 by HACETTEPE UNIVERSITY http://aac.asm.org/ Downloaded from ml/min served as a loading solution. After 1.00 minute of loading, a mixture of 20 250 mM ammonium acetate and acetonitrile (1:4, mobile phase B) was used to elute the 251 analytes from the trapping to the chiral column (Lux Cellulose-2 (150x4.6 mm, 3 µm, 252
Phenomenex, CA, USA)), with a flow rate ascending to reach 0.4 ml/min at 3 minutes 253 and remaining steady until 9.49 min. In the last minute (9.50-10.50), mobile phase A 254 was used again to re-equilibrate the trapping column at a flow rate of 1.0 ml/min. LC-255 MS/MS parameters are summarised in Table S4 and chromatograms are depicted in 256
Figures S1-S2. 257
Partial revalidation was performed to ensure compliance with FDA regulations, since 258 the LC-MS/MS method (34) was transferred to another system. 259
In brief, selectivity was assured by analysing 18 blank DBS extracts compared to 260 double blank (pure extraction solvent without IS) DBS samples to exclude potential 261 endogenous substances interference. Calibration lines (CL) were plotted as analyte 262 peak area (normalised to IS) vs. concentration and fitted using linear regression 263 ( Figure S3 ). The suitable weighting factor (1/x 2 ) was chosen to result in the minimal 264 total error. Accuracy and precision were determined using quality control (QC) 265 samples with known analyte concentration, 6 replicates of four concentration levels 266 across the linearity range (LLOQ, low, middle and high concentrations). By 267 comparing measured to nominal concentration (in percentage), accuracy was 268 calculated. Inter-and intra-batch precision was analysed by measuring 3 batches of 269 samples per day on 3 different days. Precision of +/− 15% (+/− 20% at LLOQ) was 270 considered adequate, while the acceptable accuracy ranged from 85-115 % (80-120% 271 at LLOQ). Possible enhancing or suppressive matrix effects were evaluated by 272 comparing the signal of biological matrix (DBS extract) and organic solvent, both 273 spiked with analytes. The stability of all entities has been reported elsewhere (28, 34) .
Quality control and standard preparation 275
The preparation of the solutions was adapted from Meister et al (34). Briefly, stock 276 solutions of the analytes were prepared freshly in acetonitrile to obtain 1.0 mg/ml 277 concentrations for R-and SPZQ, 5.0 mg/ml for R-trans-4-OH-PZQ and 1.25 mg/ml 278 PZQ is known to be influenced by food (8, 35), the treatment was administered after a 307 standardised breakfast. For PSAC, the tablets were crushed and the powder was 308 suspended in a mixture of sugar syrup and water to mask the taste. 309
DBS samples collection 310
Capillary blood (+/− 0.1 ml) was obtained using a finger pricker (e.g. Accu-check 311 Softclix Pro®; Roche, Switzerland) at 0:00, 0:30, 1:00, 1:30, 2:00, 2:30, 3:00, 6:00, 312 8:00, 10:00 and 24:00 hours after treatment with PZQ. Four drops of blood at each 313 time point were transferred on the DBS cards, dried for approximately 1 h and stored 314 afterwards in plastic bags with desiccant. The cards were transferred to Basel and kept 315 at −80°C. 316
Non-compartmental analysis 317
The following PK parameters of RPZQ, SPZQ and R-trans-4-OH-PZQ were obtained 318 using the Winnonlin software (version 5.2; Certara, Princeton, NY, USA): 319 C max maximal blood concentration (μg/ml) 320 T max time needed to reach C max (h) 321 AUC last area under the curve between 0 and the last positive concentration (h*μg/ml) 322 C max and T max are observed parameters, while T 1/2 was calculated as T 1/2 = ln2/λ. 324
Constant of elimination (λ) was determined by the program using non-linear 325
regression of the natural logarithm of concentration values in the elimination phase. 326
Since the absorption of PZQ is erratic, half-life was only estimated for those patients 327 who had a single peak in concentration and where the elimination phase was well 328 estimated by the algorithm. AUC last (AUC) was calculated from 0 to the last 329 quantifiable positive concentration, using linear trapezoidal rule. Volume of 330 distribution and renal clearance were not reported, since bioavailability is needed to 331 estimate them adequately. PK parameters were estimated for each study participant 332 and the median and IQR were calculated for patients of each treatment arm. AUC and 333
C max values of both R-and SPZQ were compared between cured and uncured patients. 334
CR was defined as the percentage of patients who were positive for infection at the 335 baseline but were not excreting eggs at the follow up. ERR was expressed as the 336 geometric mean egg output after treatment divided by the geometric mean egg output 337 before treatment (36) . 338
To compare the PK parameters, statistical analysis was conducted using Prism 339 (version 7.03, GraphPad, CA, USA). Mann-Whitney or Kruskal-Wallis multiple 340 comparison statistical test, depending on the number of groups being compared, were 341 used to study parameters of children in different treatment arms, age groups and 342 parasite species. A P value of <0.05 was considered as statistically significant. A 343 logistic regression was employed to characterize exposure-response relationship for 344 
